Sign In
Buy DARE
$2.05
-0.0900 (-4.21%)
At Close: Jun 03, 2026
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
08:17am, Thursday, 12'th May 2022
Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of 28.57% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q4 2021 Results - Earnings Call Transcript
08:18pm, Thursday, 31'st Mar 2022
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q4 2021 Results - Earnings Call Transcript
Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment
01:33pm, Thursday, 31'st Mar 2022
Organon & Co (NYSE: OGN) will license global rights to Daré Bioscience Inc's (NASDAQ: DARE) Xaciato (clindamycin phosphate vaginal gel, 2%). Xaciato is an FDA-approved medication for treating
Trading Penny Stocks? Top Stock Market News for March 31st, 2022
01:25pm, Thursday, 31'st Mar 2022 PennyStocks
Here's what you need to know about trading penny stocks on March 31st
The post Trading Penny Stocks? Top Stock Market News for March 31st, 2022 appeared first on Penny Stocks to Buy, Picks, News and I
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
01:15pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of 14.29% and 100%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Daré Bioscience Reports Full-Year 2021 Financial Results and Provides a Company Update
12:00pm, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
Entered into an exclusive global license agreement with Organon to commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%) that includes a $10 million upfront cash payment once effective
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
10:32am, Thursday, 31'st Mar 2022
Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of 14.29% and 100%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Trading Penny Stocks? Top Stock Market News for March 31st, 2022
09:25am, Thursday, 31'st Mar 2022
Here's what you need to know about trading penny stocks on March 31st The post Trading Penny Stocks? Top Stock Market News for March 31st, 2022 appeared first on Penny Stocks to Buy, Picks, News and I
Daré Bioscience to Host Full-year 2021 Financial Results and Company Update Conference Call and Webcast on March 31, 2022
12:00pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at
Daré Bioscience to Host Full-year 2021 Financial Results and Company Update Conference Call and Webcast on March 31, 2022
08:00am, Thursday, 24'th Mar 2022
SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:
Daré Bioscience to Present at the Maxim 2022 Virtual Growth Conference
08:00am, Tuesday, 22'nd Mar 2022
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and CEO, will p
Dare Bioscience Inc. (NASDAQ: DARE): Down -26.80% In 2022, Outlook Remains Negative
04:30pm, Wednesday, 09'th Mar 2022 Stocks Register
The trading price of Dare Bioscience Inc. (NASDAQ:DARE) closed lower on Tuesday, March 08, closing at $1.42, -2.07% lower than its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << Traders who pay close attention to intraday price movement should know that it fluctuated between $1.37 … Dare Bioscience Inc. (NASDAQ: DARE): Down -26.80% In 2022, Outlook Remains Negative Read More »
Daré Bioscience to Participate in Upcoming Conferences
01:00pm, Monday, 07'th Feb 2022 GlobeNewswire Inc.
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Ex
Daré Bioscience to Participate in Upcoming Conferences
08:00am, Monday, 07'th Feb 2022
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Execut
Trading Penny Stocks? Top Stock Market News for January 26th, 2022
02:44pm, Wednesday, 26'th Jan 2022 PennyStocks
Check these penny stocks out for your list on January 26th
The post Trading Penny Stocks? Top Stock Market News for January 26th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Informati
